Compare Recursion Pharmaceuticals Inc (RXRX) vs Starbucks Corp (SBUX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Recursion Pharmaceuticals Inc vs Starbucks Corp — how do they compare? Recursion Pharmaceuticals Inc trades at $3.07 (market cap $1.53B), while Starbucks Corp trades at $104.45 (market cap $119.45B). The key difference: Starbucks Corp is far larger — about 78.1× Recursion Pharmaceuticals Inc's market cap, and Starbucks Corp pays a 2.37% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| RXRX | SBUX | |
|---|---|---|
Market Cap | $1.53B | $119.45B |
Sector | Health | Consumer Cyclical |
52-Week High | $6.79 | $108.37 |
52-Week Low | $2.84 | $78.46 |
Enterprise Value | $946.50M | $142.14B |
Volume | — | 7,493,833 |
Dividend Yield | — | 2.37% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →About Starbucks Corp
Starbucks Corporation retails, roasts, and provides its own brand of specialty coffee. The Company operates retail locations worldwide and sells whole bean coffees through its sales group, direct response business, supermarkets, and on the world wide web. Starbucks also produces and sells bottled coffee drinks and a line of ice creams.
Read more on SBUX →
